Synthesis and in-vitro evaluation of platelet aggregation inhibitory activity of paeonol and its analogues

Pharmacy and Pharmacology Communications

Volumn 5, Issue 5, 1999, Pages 323-329

  Akamanchi, K G ^a   Padmawar, P A ^a   Thatte, U M ^b   Rege, N N ^b   Dahanukar, S A ^b  

^a UNIVERSITY OF MUMBAI   (India)

^b KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 METHOXYPHENYL)ETHANONE; 1 (2 HYDROXY 5 NITROPHENYL)ETHANONE; 1 (2,5 DIHYDROXYPHENYL)ETHANONE; 1 (5 CHLORO 2 HYDROXY 4 METHYLPHENYL)ETHANONE; PEONOL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0033036817     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128734910     Document Type: Article

References (14)

1. Atanas, T. A. (1994) Effect of the water extract of Galega officinalis L on human platelet aggregation in-vitro. Phytother. Res. 8: 314-316
2. Bernstein, L. H., Everse, J. (1975) Determination of the isoenzyme levels of lactate dehydrogenase. In: Colowick, S. P., Kaplan, N. O. (eds) W. A. Wood's Methods in Enzymology. Carbohydrate Metabolism. Vol 41, Academic Press, NY, pp 47-52
3. Born, G. V. R. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929
4. Cooper, S. R. (1941) Resacetophenone. Org. Synth. 21: 103-104
5. Martin, R. (1992) Uses of the Fries rearrangement for the preparation of hydroxyarylketones, a review. Org. Prep. Proc. Int. 24: 373-435
6. Schror, K. (1995) Antiplatelet drugs: a comparative review. Drugs 50: 7-28
7. Shi, L., Fan, P. S., Fang, J. X., Han, Z. X. (1988) Inhibitory effects of paeonol on experimental atherosclerosis and platelet aggregation of rabbit. Acta. Pharmacol. Sin. 9: 555-558
8. Stein, B., Fuster, V., Israel, D. H., Cohen, M., Badimon, L., Badimon, J. J., Chesebro, J. H. (1989) Potential inhibitory agents in cardiovascular disease: an update. J. Am. Coll. Cardiol. 14: 813-836
9. Venkataraman, B. V., Naga Rani, M. A. (1992) Platelets and antiplatelet drugs. Ind. J. Pharmacol. 24: 188-193
10. Verstracete, M., Zoldhelyi, P. (1995) Novel antithrombotic drugs in development. Drugs 49: 856-884
11. Vyas, G. N., Shah, N. M. (1963) Quinacetophenone monomethyl ether. Org. Synth. Coll. 4: 836-838
12. Wymann, W. E., Davis, R., Patterson, J. W., Pfister, J. R. (1988) Selective alkylations of certain phenolic and enolic function with lithium carbonate/alkylhalide. Synth. Commun. 18: 1379-1384
13. Yun-Choi, S. H., Kim, J. H., Lee, J. R. (1987) Potential inhibitors of platelet aggregation from plant sources, III. J. Nat. Prod. 50: 1059-1064
14. Zhao, T., Liu, J. (1996) Monograph of paeonol. Drugs Fut. 21: 480-482